title: Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas.
abstract: OBJECTIVE
  The usual radical radiotherapy treatment prescribed for head and neck squamous cell carcinoma (HNSCC) is 70 Gy (in 2 Gy per fraction equivalent) administered to the high-risk target volume (TV). This can be planned using either a forward-planned photon-electron junction technique (2P) or a single-phase (1P) forward-planned technique developed in-house. Alternatively, intensity-modulated radiotherapy (IMRT) techniques, including helical tomotherapy (HT), allow image-guided inversely planned treatments. This study was designed to compare these three planning techniques with regards to TV coverage and the dose received by organs at risk.
  
  
  METHODS
  We compared the dose-volume histograms and conformity indices (CI) of the three planning processes in five patients with HNSCC. The tumour control probability (TCP), normal tissue complication probability (NTCP) and uncomplicated tumour control probability (UCP) were calculated for each of the 15 plans. In addition, we explored the radiobiological rationality of a dose-escalation strategy.
  
  
  RESULTS
  The CI for the high-risk clinical TV (CTV1) in the 5 patients were 0.78, 0.76, 0.82, 0.72 and 0.81 when HT was used; 0.58, 0.56, 0.47, 0.35 and 0.60 for the single-phase forward-planned technique and 0.46, 0.36, 0.29, 0.22 and 0.49 for the two-phase technique. The TCP for CTV1 with HT were 79.2%, 85.2%, 81.1%, 83.0% and 53.0%; for single-phase forward-planned technique, 76.5%, 86.9%, 73.4%, 81.8% and 31.8% and for the two-phase technique, 38.2%, 86.2%, 42.7%, 0.0% and 3.4%. Dose escalation using HT confirmed the radiobiological advantage in terms of TCP.
  
  
  CONCLUSIONS
  TCP for the single-phase plans was comparable to that of HT plans, whereas that for the two-phase technique was lower. Centres that cannot provide IMRT for the radical treatment of all patients could implement the single-phase technique as standard to attain comparable TCP. However, IMRT produced better UCP, thereby enabling the exploration of dose escalation.
authors.affiliation: Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK. sanjoy.chatterjee@nuth.nhs.uk
authors.forename: S
authors.initials: S
authors.lastname: Chatterjee
authors.forename: N
authors.initials: N
authors.lastname: Willis
authors.forename: S M
authors.initials: SM
authors.lastname: Locks
authors.forename: J H
authors.initials: JH
authors.lastname: Mott
authors.forename: C G
authors.initials: CG
authors.lastname: Kelly
mesh_terms: D000465:Algorithms; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D011853:Radiobiology; D011874:Radiometry; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D020266:Radiotherapy, Conformal / Q000379:methods*; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods*; D036542:Tomography, Spiral Computed / Q000379:methods*
references.citation: Head Neck. 2007 Apr;29(4):387-400
references.pmid: 16358297
references.citation: Radiother Oncol. 2005 Mar;74(3):251-8
references.pmid: 15763305
references.citation: Phys Med Biol. 2006 Jul 7;51(13):R427-53
references.pmid: 16790916
references.citation: Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):123-35
references.pmid: 2032883
references.citation: Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):333-42
references.pmid: 16414369
references.citation: Semin Radiat Oncol. 1999 Jan;9(1):108-17
references.pmid: 10196402
references.citation: Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S10-9
references.pmid: 20171502
references.citation: Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):908-15
references.pmid: 18262102
references.citation: Br J Radiol. 2004 Apr;77(916):285-95
references.pmid: 15107318
references.citation: Radiother Oncol. 2008 Oct;89(1):71-80
references.pmid: 18707782
references.citation: Laryngoscope. 2008 Apr;118(4):635-9
references.pmid: 18176348
references.citation: Int J Radiat Oncol Biol Phys. 1996 Aug 1;36(1):247-51
references.pmid: 8823282
references.citation: Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S58-63
references.pmid: 20171519
references.citation: Med Dosim. 2000 Summer;25(2):71-6
references.pmid: 10856684
references.citation: Br J Radiol. 2011 Apr;84(1000):358-66
references.pmid: 21159810
references.citation: Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1535-9
references.pmid: 15925457
references.citation: Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):917-23
references.pmid: 16751074
references.citation: Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S3-9
references.pmid: 20171515
references.citation: Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):966-74
references.pmid: 17145527
references.citation: J Cancer Res Ther. 2009 Apr-Jun;5(2):107-12
references.pmid: 19542666
references.citation: Radiother Oncol. 2007 Feb;82(2):174-8
references.pmid: 17275112
references.citation: Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1252-9
references.pmid: 19251097
references.citation: Radiother Oncol. 2001 Dec;61(3):275-80
references.pmid: 11730997
references.citation: Head Neck. 2007 Mar;29(3):211-20
references.pmid: 17111429
references.citation: Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
references.pmid: 2032882
references.citation: Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):89-105
references.pmid: 12694827
references.citation: Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):178-86
references.pmid: 18565687
references.citation: Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):83-8
references.pmid: 12694826
references.citation: Cancer. 2008 Aug 1;113(3):497-507
references.pmid: 18521908
references.citation: Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):695-704
references.pmid: 11395238
references.citation: Clin Oncol (R Coll Radiol). 2012 Dec;24(10):e173-9
references.pmid: 23079100
references.citation: Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):589-96
references.pmid: 18793962
references.citation: Radiat Oncol. 2008 Dec 09;3:41
references.pmid: 19068126
references.citation: Radiother Oncol. 2007 Oct;85(1):36-41
references.pmid: 17709149
references.citation: Radiother Oncol. 2005 Nov;77(2):148-56
references.pmid: 16260056
references.citation: Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8
references.pmid: 19111400
references.citation: Phys Med Biol. 1994 Nov;39(11):2091-8
references.pmid: 15560013